Skip to main content
CANN GROUP LIMITED logo

CANN GROUP LIMITED — Investor Relations & Filings

Ticker · CAN ISIN · AU000000CAN2 LEI · 529900XX42XELLXVQE42 ASX Manufacturing
Open in API
Filings indexed 729 across all filing types
Latest filing 2022-01-19 Capital/Financing Update
Country AU Australia
Listing ASX CAN

About CANN GROUP LIMITED

https://www.canngrouplimited.com/

Cann Group Limited specializes in the cultivation, manufacture, and supply of medicinal cannabis products. The company focuses on providing pharmaceutical-grade cannabis for therapeutic use, utilizing advanced greenhouse technology and automated cultivation systems to ensure standardized quality and consistency. Its operations encompass the entire supply chain, from plant genetics and breeding to the production of finished medicinal products, including oils and dried flower. Cann Group serves healthcare professionals and patients through established distribution channels and maintains a focus on research and development to advance cannabinoid-based treatments. The company leverages large-scale production capabilities to meet growing demand in both domestic and international medicinal markets, emphasizing rigorous quality control and compliance with international pharmaceutical standards.

Recent filings

Filing Released Lang Actions
Rua shareholders approve acquisition of Zalm Therapeutics 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 20 January 2022 regarding the approval by Rua shareholders of the acquisition of Zalm Therapeutics. It references a previous announcement and provides contact information and company background. The content is an update on a financing/transaction event (shareholder approval of an acquisition) rather than a full report, financial statements, or detailed management discussion. It does not contain financial data or detailed report content but is an announcement related to a capital transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short (2243 characters), consistent with an announcement rather than a full report.
2022-01-19 English
Application for quotation of securities - CAN 7 pages 30.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by Cann Group Limited. It details the number and type of securities to be quoted, issue dates, and information about key management personnel receiving securities. The document is a formal announcement related to the listing of new securities on the ASX and does not contain financial statements or performance data. It is not a report like an Annual Report or Interim Report, nor is it a regulatory certification or legal proceeding. The content fits the category of a Share Issue/Capital Change announcement, as it relates to new shares being issued and quoted on the exchange.
2022-01-12 English
Notification regarding unquoted securities - CAN 7 pages 30.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics such as the number of securities issued, dates, and mentions key management personnel receiving securities. The document is an announcement of a securities issuance event, specifically related to employee incentive plans and unquoted equity securities. It does not contain financial statements, audit information, or detailed financial results. It is not a report but an announcement of a capital change event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (6459 characters) supports it being a detailed announcement rather than a brief notice or a full report.
2021-12-20 English
Issue of performance rights to senior executives 1
Remuneration Information Classification · 95% confidence The document is an ASX announcement dated 21 December 2021 regarding the issue of performance rights to senior executives under the company's Long Term Incentive Plan (LTIP). It details the number of performance rights issued, the conditions for vesting, and specific information about the CEO's performance rights. There is no financial data, no report attached or referenced as being published, and no mention of a full report or regulatory certification. The content focuses on executive compensation through performance rights issuance, which aligns with remuneration information filings. Therefore, the document fits best under the Remuneration Information category (DEF 14A). The document length is under 5,000 characters and is a direct announcement, not a report or certification, so it is not RPA or RNS.
2021-12-20 English
Cann receives $2.186m R&D tax rebate 1 page 182.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 6 December 2021, stating that Cann Group Limited has received a $2.186 million R&D tax rebate for the 2021 financial year. It describes the nature of the rebate and the company's plans to reinvest the funds. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is short (2953 characters) and serves as a notification of receipt of a tax rebate rather than a full financial report or detailed management discussion. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is an announcement of a financial event related to R&D tax incentives, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-12-05 English
Cann to sell interest in Zalm Therapeutics 3 pages 174.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 30 November 2021 regarding Cann Group Limited's sale of its interest in Zalm Therapeutics to Rua Bioscience. It details the transaction terms, payment milestones, and changes in board membership related to Zalm. The content focuses on a corporate transaction involving share issuance and supply agreements, with no financial statements or earnings data presented. The document is a formal announcement of a capital transaction rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (7349 characters) supports it being a detailed announcement rather than a brief notice or a full report like an Annual or Interim Report.
2021-11-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.